Search results
Psoriasis study shows high level of arthritis symptoms in patients
Medical Xpress· 3 days agoThe study led by researchers at the Universities of Oxford, University College Dublin and supported...
Polycystic Ovarian Syndrome: New Science Offers Old Remedy
Medscape· 4 days agoAn ancient Chinese remedy for malaria could offer new hope to the 10% of reproductive-age women...
Resurrecting an Old Therapy Against a Growing Antibiotic Crisis
WebMD· 1 day agoThomas Patterson was on vacation in Egypt with his wife when he first became sick. Patterson was infected with Acinetobacter baumannii, which the World Health Organization would later name the ...
Why Is My Skin So Itchy?
Verywell Health via Yahoo News· 3 days agoPruritus, or itchy skin, is a characteristic feature of many skin diseases and an unusual sign of some systemic diseases. It can be painful or...
In a 'gold rush' for treating bowel disease, AbbVie clears one more stage
Crain s Chicago Business· 2 days agoWith the arrival of biosimilar competition for its blockbuster drug Humira, AbbVie has said much of its sales growth potential lies with these two anti-inflammatories. In April, the North Chicago ...
Johnson & Johnson submits application to U.S. FDA seeking approval of TREMFYA® (guselkumab) for the...
Morningstar· 1 day agoJohnson & Johnson (NYSE: JNJ) today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking approval of TREMFYA ...
States struggle to help patients navigate insurance hurdle known as ‘step therapy’
Missouri Independent via Yahoo News· 5 days agoCassidy Yermal, 32, began experiencing debilitating migraines when she was 17 years old. As a...
How AI Is Revolutionizing Drug Development
The New York Times via Yahoo News· 4 days agoMONROVIA, Calif. — The laboratory at Terray Therapeutics is a symphony of miniaturized automation. Robots whir, shuttling tiny tubes of fluids to their...
U.S. FDA Approves SKYRIZI® (risankizumab-rzaa) for Ulcerative Colitis, Expanding AbbVie's Portfolio...
Morningstar· 3 days agoApproval supported by two Phase 3 clinical trials that evaluated SKYRIZI® for the treatment of moderate to severe ulcerative colitis: a 12-week induction study, INSPIRE,1 and a 52-week maintenance study, COMMAND2Data showed that clinical remission,
How Neuroscience Is Leading the Next Wave of Skin-Care Innovation
PopSugar· 1 day agoNot to mention, aromatherapy uses scent to affect mood and CBD products bind to cannabinoid...